The School of Pharmacy at the University of Nottingham carries out research and training on the synthesis, characterization and biomedical applications of new drugs and drug delivery materials, as well as the detailed study of existing biomaterials and drug delivery systems at the molecular, cellular and macro scale.
All of these aspects particularly well complement the other teams of the consortium. The teams have an international reputation for ‘smart’ materials and polymer-biopolymer conjugates and a world-leading role in tissue engineering and regenerative medicine. They have pioneered scanning probe microscopies and spectroscopies, and high-throughput surface analytical techniques for pharmaceutical applications. Two groups are working on the development of nanosensors for use in live cell imaging on chemical synthesis and drug-carrier formulations.

Role in the NanoFar consortium

Within the Nanofar consortium, the Nottingham group will be in charge of the professional insertion of the PhD researchers. The School of Pharmacy at Nottingham has a proven track record in provision of innovative training to equip scientists for careers in the pharmaceutical area and for the future in nanomedicine. The quality of doctoral programmes has been recognised by the EPSRC and AstraZeneca awards to establish a Doctoral Training Centre in Targeted Therapeutics and a Marie-Curie Training Site in Drug Delivery and Tissue Engineering. In addition the School is partner in the Regenerative Medicine Doctoral Training Centre, also funded by the EPSRC. Those training programmes that are innovative, industrially relevant and end-use oriented will be applied across the NanoFar consortium to immerse PhD researchers in a wide range of scientific, professional and personal development activities in order to ensure a successful transition between the university and a pharmaceutical career.

Website: The University of Nottingham